NEW YORK, Sept. 14, 2024 /PRNewswire/ — The article has been published by China Daily on Sept. 13: Qu Yingpu (right), publisher and editor-in-chief of China Daily; Hu Wei (left), president and CEO of Bank of China USA, and guest speakers holding their souvenir portraits pose for a photo at the Vision China event in […]
Category Archives: Pr Newswire
RIYADH, Saudi Arabia, Sept. 14, 2024 /PRNewswire/ — Leading-edge artificial intelligence algorithms are now powering production at nearly half of VSPO’s esports tournaments, dramatically reducing content creation time and enhancing fan engagement, said the company’s co-founder Danny Tang at the New Global Sport Conference 2024 (“NGSC”) in Riyadh this August. Danny Tang, co-founder, CFO and […]
The first publication of clinical data for YL201, featured in an oral presentation at ESMO 2024. Encouraging antitumor activity of YL201 in multiple solid tumor types, including SCLC, NPC, and wild-type NSCLC, from Phase I escalation and expansion results. In extensive-stage SCLC patients, ORR was 68.1% and mPFS was 6.2 months. SUZHOU, China, Sept. 14, […]
13
Sep
Sep
SOUTH SAN FRANCISCO, Calif., Sept. 13, 2024 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option to purchase an […]
13
Sep
Sep
SAN DIEGO, Sept. 13, 2024 (GLOBE NEWSWIRE) — Tr1X, Inc. (pronounced “Trix”), a biopharmaceutical company specializing in allogeneic engineered Treg and CAR-Treg cell therapies with the potential to cure autoimmune and inflammatory diseases, today announced the attendance and participation of select members of the management team at the following upcoming investor conferences: Goldman Sachs Inaugural […]
13
Sep
Sep
RIYADH, Saudi Arabia, Sept. 13, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSHRC) has reiterated its commitment to ethical innovation in its efforts to champion medical research and patient care. KFSHRC ensures that its integration of novel technologies, such as AI and CRISPR, is guided by rigorous ethical frameworks prioritizing transparency, […]
Pr Newswire
MetasTx Welcomes Esteemed Cancer Scientist Dr. Jonathan Chernoff to the Board of Managers
13
Sep
Sep
Renowned Cancer Researcher Brings Deep Expertise to Accelerate MetasTx’s Mission to Combat Metastatic Cancer PHILADELPHIA, Sept. 13, 2024 (GLOBE NEWSWIRE) — MetasTx, a pioneering biopharmaceutical company dedicated to developing novel therapeutics to treat and prevent cancer metastasis, is pleased to announce that Jonathan Chernoff, MD, PhD, has joined its Board of Managers. Dr. Chernoff, who […]
13
Sep
Sep
Funds will advance the development of ONL1204 Ophthalmic Solution with the initiation of a Phase 2 global study for the treatment of geographic atrophy (GA) associated with dry age-related macular degeneration (AMD) ANN ARBOR, Mich., Sept. 13, 2024 (GLOBE NEWSWIRE) — ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision […]
SHANGHAI, Sept. 13, 2024 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today was informed by co-founders of the Company, Dr. Gang Yu and Mr. Junling Liu, that they […]
LONDON, Sept. 13, 2024 /PRNewswire/ — ATFX Connect, the trading name of AT Global Markets (UK) Limited (“ATFX”), announces the addition of Non-Deliverable Forwards (“NDFs”) to its product portfolio. This additional offering will provide the company’s global client base with access to pricing and currency markets in Asia and LATAM. This significant addition means that […]